Sai Life Sciences had an eventful Pharma Integrates 2024! Nathalie Huther moderated an engaging panel on ‘The Three Cs – CDMO, CRO, and Change,’ which featured speakers who shared their expertise on navigating the evolving landscape of contract development, manufacturing, and outsourcing. The discussion highlighted how CDMOs & CROs are adapting to regulatory, technological, and market shifts to meet the changing needs of the industry. Emma Hunt joined a panel discussing ‘How can pharma supply chains and partnerships respond to the dynamics of the pharmaceutical market?’. Key takeaways included the need for increased agility, the role of collaboration in risk mitigation and using digital platforms to achieve this. We thank all the attendees, speakers, and visitors for connecting with Sai Life Sciences team at the event. #sailifesciences #drugdevelopment #drugdiscovery #cdmo #cro #pharma #pharmaintegrates
Interesting event and worth attending
Many thanks Nathalie Huther PhD MBA and Emma Hunt for sharing such valuable insights and to Sai Life Sciences Ltd for your continued support - very much appreciated (!)
--
2wFDA researchers state once ophthalmic drug Review completed, all generic drug prices bringing the price down by 80% approximately?